Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 15.53
-0.17 (-1.08%)
Aug 14, 2026, 3:00 PM CST
Guobang Pharma Revenue
Guobang Pharma had revenue of 1.62B CNY in the quarter ending June 30, 2026, with 2.23% growth. This brings the company's revenue in the last twelve months to 6.13B, up 1.71% year-over-year. In the year 2025, Guobang Pharma had annual revenue of 6.01B with 2.05% growth.
Revenue (ttm)
6.13B
Revenue Growth
+1.71%
P/S Ratio
1.96
Revenue / Employee
1.44M
Employees
4,251
Market Cap
11.99B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.01B | 120.56M | 2.05% |
| Dec 31, 2024 | 5.89B | 541.39M | 10.12% |
| Dec 31, 2023 | 5.35B | -371.48M | -6.49% |
| Dec 31, 2022 | 5.72B | 1.22B | 26.98% |
| Dec 31, 2021 | 4.51B | 299.03M | 7.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.